-transparent.png){kind=logo}
Immunoreactive leukotriene B4 (iLTB4), detected in the pleural cavity following induction of a reverse passive Arthus reaction (RPAR), was inhibited by the mixed lipoxygenase-cyclooxygenase inhibitors, phenidone and BW 755C, but not by cyclooxygenase inhibitors or by chlorpheniramine or methysergide. Both iLTB4 production and the subsequent pleural inflammation were dependent upon the dose of BSA antigen employed to elicit the RPAR pleurisy. However, inasmuch as BW 755C and phenidone were not distinguished from the cyclooxygenase inhibitors in their effects on fluid accumulation and cellular infiltration in RPAR pleurisy, it is doubtful that LTB4 plays a functional role in this inflammation model.
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
September 1992,
British journal of pharmacology,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
October 1984,
Agents and actions,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
August 1995,
Inflammation research : official journal of the European Histamine Research Society ... [et al.],
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
October 1985,
Biochemical pharmacology,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
April 1978,
Clinical immunology and immunopathology,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
January 1983,
Clinical immunology and immunopathology,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
January 1988,
Annals of the New York Academy of Sciences,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
October 1978,
Agents and actions,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
August 1961,
Nederlands tijdschrift voor geneeskunde,
B M Weichman, and
J W Berkenkopf, and
C A Cullinan, and
R J Sturm
September 1991,
American journal of respiratory cell and molecular biology,
